NEXT-ChemX Corporation.

CIK:0001657045|SEC Filings

Statement of Operations - USD ($)	12 Months Ended
Statement of Operations - USD ($)	Dec. 31, 2024	Dec. 31, 2023
Income Statement [Abstract]
Revenues
Operating expenses
Salaries and Employee Benefits	760,954	1,078,341
Professional fees and contractors	717,676	684,127
Depreciation and Amortization	155,118	155,118
Other operating Expenses	497,353	208,797
Total operating expenses	2,131,101	2,126,383
Income (loss) from operations	(2,131,101)	(2,126,383)
Other income (expense)
Interest expense	(186,700)	(87,682)
Other income (expense)	34,989	(296,948)
Net other expense	(151,711)	(384,630)
Loss before provision for income taxes	(2,282,812)	(2,511,013)
Net income (loss)	$ (2,282,812)	$ (2,511,013)
Net income (loss) per common share, Basic	$ (0.08)	$ (0.09)
Net income (loss) per common share, Diluted	$ (0.08)	$ (0.09)
Weighted average number of common shares outstanding, Basic	28,546,834	28,466,560
Weighted average number of common shares outstanding, Diluted	28,546,834	28,466,560

Statement of Cash Flows - USD ($)	12 Months Ended
Statement of Cash Flows - USD ($)	Dec. 31, 2024	Dec. 31, 2023
OPERATING ACTIVITIES
Net income(loss)	$ (2,282,812)	$ (2,511,013)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	155,118	155,118
Other income received in 3rd party stock	(38,549)	(203,050)
Unrealized loss on trading securities	(12,154)	36,581
Consultant commission paid in third party stock	38,549	101,525
Other Expense paid in stocks		500,000
Changes in Operating Assets and Liabilities:
Accounts payable and accrued liabilities	714,051	1,394,467
Prepaid expenses	(8,341)	(50,756)
Write-off of Other Receivables	437,597
Related Party advances	75,207	32,238
Net cash provided by (used in) operating activities	(921,334)	(544,890)
INVESTING ACTIVITIES
Purchase of Property and Equipment
Other Receivables	(437,597)
Net cash provided by investing activities	(437,597)
FINANCING ACTIVITIES
Proceeds from the Stock Issuance of Common Stocks		500,000
Proceeds from loan payables	20,000	465,000
Proceeds from note payables	1,411,000
Repayment of loan payable		(20,000)
Repayment of note payable		(426,007)
Repayment of equity escrow account	(11,980)
Net cash (used in) financing activities	1,419,020	518,993
Net increase (decrease) in cash	60,089	(25,897)
Cash, beginning of year	2,458	28,355
Cash, end of year	62,547	2,458
Cash paid during the period for:
Income tax
Interest		37,212
Supplemental non-cash investing and financing activities
Conversion of loan to convertible note	$ 174,004

Balance Sheets - USD ($)	Dec. 31, 2024	Dec. 31, 2023
Current Assets:
Cash	$ 62,547	$ 2,458
Prepaid expense and other current assets	81,266	72,925
Investments	77,098	64,944
Total Current Assets	220,911	140,327
Non-Current Assets:
Property and equipment, net	7,285	12,621
Intangible asset, net	2,542,185	2,691,967
Total Assets	2,770,381	2,844,915
Current Liabilities:
Accounts payable and accrued liabilities	3,103,254	2,443,207
Total Current Liabilities	3,710,699	2,987,425
Non-Current Liabilities:
Notes Payable	2,430,004	945,000
Total Non-Current Liabilities	2,430,004	945,000
Total Liabilities	6,140,703	3,932,425
Stockholders’ Equity (Deficit):
Preferred stock, value	40
Preferred stocks subscription receivables	(40)
Common stock, $0.001 par value, 100,000,000 shares authorized, 28,546,834 shares issued and outstanding as of December 31, 2024 and 2023.	28,547	28,547
Additional paid-in capital	5,396,053	5,396,053
Accumulated deficit	(8,794,922)	(6,512,110)
Total Stockholders’ Equity (Deficit)	(3,370,322)	(1,087,510)
Total Liabilities and Stockholders’ Equity (Deficit)	2,770,381	2,844,915
Series A Preferred Stock [Member]
Stockholders’ Equity (Deficit):
Preferred stock, value	20
Series F Preferred Stock [Member]
Stockholders’ Equity (Deficit):
Preferred stock, value	20
Nonrelated Party [Member]
Current Liabilities:
Due to Related Party	500,000	511,980
Related Party [Member]
Current Liabilities:
Due to Related Party	$ 107,445	$ 32,238